# China biotech
Latest news and articles about China biotech
Total: 3 articles found
China Installs First Superconducting Linac for Mass Production of Scarce Alpha Cancer Isotopes
China’s Institute of Modern Physics has installed the main accelerator for IP-SAFE, a superconducting linac demonstrator intended to mass-produce scarce alpha-emitting isotopes Ac-225 and Ra-223. The facility aims to ease global shortages that constrain targeted alpha therapies and to bolster domestic biomedical and accelerator capabilities.
Chinese Drugmaker Huadong Advances RNAi Weight‑loss Candidate into Preclinical Studies
Huadong Medicine and Suzhou Shian Biotech have confirmed a preclinical siRNA candidate aimed at an innovative weight‑loss mechanism and entered preclinical research. The move underscores China’s push into RNAi therapeutics for metabolic disease, but substantial scientific, delivery and regulatory challenges lie ahead before any clinical testing.
China CRO Pumps Profits by Stockpiling Lab Monkeys and Cash — but Sustainability Is in Doubt
Zhaoyan New Drug posted a paradoxical 2025 outlook: lower revenue but sharply higher net profit driven mainly by fair‑value gains on biological assets — chiefly experimental monkeys — and returns from cash management. The company’s core laboratory services remain under pressure, and the profitability bump has prompted scrutiny about the sustainability of relying on asset revaluation and financial income rather than scientific capabilities.